Collado-Mateo Daniel, Adsuar José C, Olivares Pedro R, García-Gordillo Miguel Ángel
Facultad de Ciencias del Deporte, Universidad de Extremadura, Cáceres, España.
Instituto de Actividad Física, Salud y Calidad de Vida, Universidad Autónoma de Chile, Talca, Chile.
Rev Med Chil. 2017 Feb;145(2):147-155. doi: 10.4067/S0034-98872017000200001.
Chronic obstructive pulmonary disease (COPD) has a relevant impact on health-related quality of life (HRQoL). Short Form 6 dimensions (SF-6D) quality of life tool allows researchers to calculate preference-based utilities using data from SF-12 or SF-36 questionnaires.
To provide normative values of SF-6D derived from SF-12 for Chilean patients with COPD.
SF-6D utility index was calculated using data from the 2009/2010 Chilean National Health Survey. Sixty-nine male and 120 female patients with COPD participated in the survey. Data was stratified by gender, age, region, marital status, smoking status, monthly incomes, educational level and area.
The mean (± SD) SF-6D utility index for Chilean patients with COPD was 0.65 ± 0.15. The scores for men and women were 0.68 ± 0.15 and 0.64 ± 0.15, respectively. Patients with high incomes and educational level reported higher SF-6D scores. Ceiling effect was not a limitation when SF-6D was used in these Chilean patients.
The current study provides normative values of SF-6D derived from SF-12 for Chilean patients with COPD.
慢性阻塞性肺疾病（COPD）对健康相关生活质量（HRQoL）有显著影响。简式36健康调查简表6维度（SF - 6D）生活质量工具使研究人员能够利用来自SF - 12或SF - 36问卷的数据计算基于偏好的效用值。
为智利慢性阻塞性肺疾病患者提供从SF - 12得出的SF - 6D的标准值。
使用2009/2010年智利全国健康调查的数据计算SF - 6D效用指数。69名男性和120名女性慢性阻塞性肺疾病患者参与了该调查。数据按性别、年龄、地区、婚姻状况、吸烟状况、月收入、教育水平和地区进行分层。
智利慢性阻塞性肺疾病患者的平均（±标准差）SF - 6D效用指数为0.65±0.15。男性和女性的得分分别为0.68±0.15和0.64±0.15。高收入和高教育水平的患者报告的SF - 6D得分更高。在这些智利患者中使用SF - 6D时，天花板效应不是一个限制因素。
本研究为智利慢性阻塞性肺疾病患者提供了从SF - 12得出的SF - 6D的标准值。
